Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.43821 | 95 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.56127 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.42391 | 95 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.6273 | 95 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.64579 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.31844 | 95 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.38661 | 92 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.25375 | 95 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.4026 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.47924 | 95 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.34418 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.48385 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.24862 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.5594 | 95 |